---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-001717"
form_type: "8-K"
ticker: "SRTS"
cik: "0001494891"
company_name: "Sensus Healthcare, Inc."
filed_at: "2023-01-09T23:59:59+00:00"
generated_at: "2026-06-20T17:44:23.053385+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Preliminary FY2022 revenue exceeds $44M (60% growth); profitable Q4 and FY; COO appointed

## Summary
- Preliminary Q4 2022 revenues expected to exceed $13M; full-year 2022 revenues exceed $44M (60% growth over 2021).
- Sensus expects both Q4 and full-year 2022 to be profitable; Q4 aesthetics revenue over $500K.
- Magdalena Martinez named COO, replacing Nicolas Soro, effective January 3, 2023. She previously served as VP of Operations.
- Company plans to expand sales force, increase trade show presence, and submit new technologies to FDA in H2 2023.

## SEC filing metadata
- accession: 0001213900-23-001717
- form_type: 8-K
- ticker: SRTS
- cik: 0001494891
- company_name: Sensus Healthcare, Inc.
- filed_at: 2023-01-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1494891/000121390023001717/0001213900-23-001717-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1494891/000121390023001717/ea171415-8k_sensus.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-001717
- JSON: https://secwatch.observer/filing/0001213900-23-001717.json
- Plain text: https://secwatch.observer/filing/0001213900-23-001717.txt

## Key facts
- Earnings Releases
  Sensus Healthcare, Inc. reported the fourth quarter and full year ended December 31, 2022 results: revenue exceed $13 million.
  - Period: the fourth quarter and full year ended December 31, 2022
  - Revenue: exceed $13 million
  - Result: preliminary results
  source text: PRESS RELEASE, DATED JANUARY 5, 2023. Exhibit 99.1 Sensus Healthcare Announces Preliminary Fourth Quarter 2022 Revenues Fourth quarter revenues to exceed $13 million; full year revenues to exceed $44 million, representing growth of 60% BOCA RATON, Fla, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS ), a medical device
  evidence_url: https://www.sec.gov/Archives/edgar/data/1494891/000121390023001717/0001213900-23-001717-index.htm
- Executive change
  Nicolas Soro departed as Chief Operating Officer at Sensus Healthcare, Inc..
  - Action: replaced
  - Role: Chief Operating Officer
  source text: On January 3, 2023, Magdalena Martinez was elected Chief Operating Officer of Sensus, replacing Nicolas Soro.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1494891/000121390023001717/0001213900-23-001717-index.htm
- Executive change
  Magdalena Martinez was elected as Chief Operating Officer at Sensus Healthcare, Inc..
  - Action: elected
  - Role: Chief Operating Officer
  source text: On January 3, 2023, Magdalena Martinez was elected Chief Operating Officer of Sensus, replacing Nicolas Soro.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1494891/000121390023001717/0001213900-23-001717-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.